Literature DB >> 22526875

Treatment of symptomatic para-articular intraosseous cysts by percutaneous injection of bone cement.

Boris Maurel1, Thomas Le Corroller, Guillaume Bierry, Xavier Buy, Philippe Host, Afshin Gangi.   

Abstract

PURPOSE: To describe the technique and clinical outcome of percutaneous injection of bone cement in the treatment of symptomatic para-articular intraosseous cysts.
MATERIALS AND METHODS: Five patients (three men, two women; mean age 35 years) with painful para-articular intraosseous cysts were treated by percutaneous injection of bone cement under combined fluoroscopic and computed tomography (CT) guidance. The lesions were all located in weight-bearing bones, involving the acetabulum, proximal tibia, distal tibia, talus, and calcaneus, respectively.
RESULTS: The average amount of bone cement injected was 2.1 ml (range, 0.6-3.5 ml). Calcium phosphate cement was used in four cases and acrylic cement in one case. There were no immediate or delayed complications. Full pain relief was obtained between 1 and 4 weeks after treatment. All patients made a complete recovery and were pain-free at their last visit.
CONCLUSIONS: Percutaneous injection of bone cement was a safe and efficient technique in the management of symptomatic para-articular intraosseous cysts in our population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22526875     DOI: 10.1007/s00256-012-1392-7

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  21 in total

1.  Rapid chondrolysis after an intra-articular leak of bone cement in treatment of a benign acetabular subchondral cyst: an unusual complication of percutaneous injection of acrylic cement.

Authors:  A Leclair; A Gangi; F Lacaze; R M Javier; O Bonidan; J F Kempf; F Bonnomet; F X Limbach; J L Kuntz; J L Dietmann; J Sibilia
Journal:  Skeletal Radiol       Date:  2000-05       Impact factor: 2.199

2.  Ex vivo biomechanical comparison of hydroxyapatite and polymethylmethacrylate cements for use with vertebroplasty.

Authors:  Stephen M Belkoff; John M Mathis; Louis E Jasper
Journal:  AJNR Am J Neuroradiol       Date:  2002 Nov-Dec       Impact factor: 3.825

3.  Intraosseous ganglion cyst of the lunate: diagnosis and management.

Authors:  S Tham; D C Ireland
Journal:  J Hand Surg Br       Date:  1992-08

4.  [Pathological fracture of the carpal scaphoid (intra-osseous synovial cyst). Clinical and therapeutic aspect. Case report].

Authors:  M Yakoubi; N Meziani; M Yahia Cherif; A Zemmouri; R Benbakouche
Journal:  Chir Main       Date:  2008-12-17

5.  Autogenous iliac crest bone graft. Complications and functional assessment.

Authors:  J A Goulet; L E Senunas; G L DeSilva; M L Greenfield
Journal:  Clin Orthop Relat Res       Date:  1997-06       Impact factor: 4.176

6.  Percutaneous vertebroplasty guided by a combination of CT and fluoroscopy.

Authors:  A Gangi; B A Kastler; J L Dietemann
Journal:  AJNR Am J Neuroradiol       Date:  1994-01       Impact factor: 3.825

7.  Therapeutic percutaneous injections in the treatment of malignant acetabular osteolyses.

Authors:  A Cotten; X Demondion; N Boutry; B Cortet; P Chastanet; B Duquesnoy; D Leblond
Journal:  Radiographics       Date:  1999 May-Jun       Impact factor: 5.333

Review 8.  Bilateral scaphoid ganglion cysts in an adolescent.

Authors:  S E Logan; L A Gilula; M Kyriakos
Journal:  J Hand Surg Am       Date:  1992-05       Impact factor: 2.230

9.  [Intraosseus synovial cysts of the lunate bone: diagnostic problems].

Authors:  G Calcagnotto; C Sokolow; P Saffar
Journal:  Chir Main       Date:  2004-02

10.  Juxta-articular bone cysts (intra-osseous ganglia): a clinicopathological study of eighty-eight cases.

Authors:  F Schajowicz; M Clavel Sainz; J A Slullitel
Journal:  J Bone Joint Surg Br       Date:  1979-02
View more
  1 in total

1.  Endoscopic Treatment of Symptomatic Foot and Ankle Bone Cyst with 3D Printing Application.

Authors:  Changgui Zhang; Jin Cao; Hongli Zhu; Huaquan Fan; Liu Yang; Xiaojun Duan
Journal:  Biomed Res Int       Date:  2020-12-26       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.